In our recent podcast lead by Prod. Jean-François Dufour, we had the privilege of speaking with Professor Michel Ducreux, a leading expert in the field of oncology from Paris, France. The discussion focused on the evolving landscape of colorectal cancer treatment and the latest advancements that are reshaping patient care. Below you will find the
Month: August 2024
Exploring New Frontiers in Hepatocellular Carcinoma Treatment: Insights from the CheckMate 9DW Trial
In our latest “Ask the Author” session, Professor Peter Galle presented the groundbreaking results of the CheckMate 9DW clinical trial, which explored the efficacy of the combination of nivolumab and ipilimumab versus lenvatinib or sorafenib as first-line treatments for unresectable hepatocellular carcinoma (HCC). Below you will find the video as well as the summary: Background: